View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - CLL17 - Obinutuzumab (100/900/1000) / Venetoclax 20, Chronic Lymphocytic Leukemia, cycle 1
Protocol-ID: 1854 V1.0 (Mini), Study-CLL17-OBIN(100/900/1000)/VNTC20, CLL, C1Study protocol, available to authorized participants only.
Indication(s)
- Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma; ICD-10 C91.1-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 31.10.2021